DHTKD1 and neoplasm: Based on these anti-tumorigenic activities of E1A, we sought to determine if E1A could be used to enhance antigen specific, anti-tumor T cell responses to MCA-205 tumor cells that express a model tumor antigen, ovalbumin (OVA).